Sun Pharmaceutical Industries Limited - Laporan Laba Rugi (TTM)

Sun Pharmaceutical Industries Limited
IN ˙ NSEI ˙ INE044A01036
₹ 1,594.70 ↑12.35 (0.78%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Sun Pharmaceutical Industries Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 324,782 331,601 334,981 356,316 367,044 377,307 386,545 396,975 410,239 424,018 438,857 450,648 463,049 474,446 484,968 492,088 503,077 516,025 525,784 537,771
Change (%) 2.10 1.02 6.37 3.01 2.80 2.45 2.70 3.34 3.36 3.50 2.69 2.75 2.46 2.22 1.47 2.23 2.57 1.89 2.28
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 90,699 92,033 92,185 93,699 102,739 105,811 108,761 106,023 113,131 114,762 113,187 111,766 112,557 111,889 114,422 113,594 112,666 112,702 115,584 116,978
Change (%) 1.47 0.17 1.64 9.65 2.99 2.79 -2.52 6.70 1.44 -1.37 -1.25 0.71 -0.59 2.26 -0.72 -0.82 0.03 2.56 1.21
% of Revenue 27.93 27.75 27.52 26.30 27.99 28.04 28.14 26.71 27.58 27.07 25.79 24.80 24.31 23.58 23.59 23.08 22.40 21.84 21.98 21.75
Gross Operating Profit 234,083 239,568 242,796 262,617 264,306 271,496 277,784 290,952 297,107 309,256 325,670 338,881 350,492 362,557 378,342 378,493 390,412 403,324 410,200 420,793
Change (%) 2.34 1.35 8.16 0.64 2.72 2.32 4.74 2.12 4.09 5.31 4.06 3.43 3.44 4.35 0.04 3.15 3.31 1.70 2.58
% of Revenue 72.07 72.25 72.48 73.70 72.01 71.96 71.86 73.29 72.42 72.93 74.21 75.20 75.69 76.42 78.01 76.92 77.60 78.16 78.02 78.25
SG&A 67,016 68,729 69,042 68,619 70,049 71,354 73,544 76,169 78,688 80,549 83,549 86,821 90,419 93,681 95,025 95,551 96,684 98,574 100,509 103,979
Change (%) 2.56 0.46 -0.61 2.08 1.86 3.07 3.57 3.31 2.37 3.72 3.92 4.14 3.61 1.43 0.55 1.19 1.95 1.96 3.45
% of Revenue 20.63 20.73 20.61 19.26 19.08 18.91 19.03 19.19 19.18 19.00 19.04 19.27 19.53 19.75 19.59 19.42 19.22 19.10 19.12 19.34
R&D
Change (%)
% of Revenue
OpEx 272,060 272,980 270,705 282,743 289,424 297,080 305,073 316,848 325,518 336,460 345,809 352,323 364,799 372,364 380,665 383,641 388,588 393,218 399,730 408,025
Change (%) 0.34 -0.83 4.45 2.36 2.65 2.69 3.86 2.74 3.36 2.78 1.88 3.54 2.07 2.23 0.78 1.29 1.19 1.66 2.08
% of Revenue 83.77 82.32 80.81 79.35 78.85 78.74 78.92 79.82 79.35 79.35 78.80 78.18 78.78 78.48 78.49 77.96 77.24 76.20 76.03 75.87
Operating Income 52,722 58,621 64,276 73,573 77,620 80,227 81,472 80,128 84,721 87,557 93,048 98,324 98,250 102,082 105,202 108,447 114,490 122,807 126,055 129,746
Change (%) 11.19 9.65 14.46 5.50 3.36 1.55 -1.65 5.73 3.35 6.27 5.67 -0.08 3.90 3.06 3.08 5.57 7.26 2.64 2.93
% of Revenue 16.23 17.68 19.19 20.65 21.15 21.26 21.08 20.18 20.65 20.65 21.20 21.82 21.22 21.52 21.69 22.04 22.76 23.80 23.97 24.13
Interest Expense -2,000 -1,631 -1,414 -1,246 -1,272 -1,201 -1,274 -1,060 -894 -1,166 -1,720 -2,392 -2,691 -2,576 -2,385 -2,191 -2,390 -2,558 -2,314 -2,446
Change (%) -18.43 -13.29 -11.92 2.14 -5.60 6.03 -16.80 -15.63 30.44 47.51 39.06 12.50 -4.26 -7.44 -8.11 9.07 7.02 -9.55 5.73
% of Revenue -0.62 -0.49 -0.42 -0.35 -0.35 -0.32 -0.33 -0.27 -0.22 -0.27 -0.39 -0.53 -0.58 -0.54 -0.49 -0.45 -0.48 -0.50 -0.44 -0.45
Net Income 14,706 24,095 29,038 60,036 62,378 64,441 32,727 38,894 41,046 42,119 84,736 84,352 85,485 89,063 95,764 103,895 110,541 114,337 109,290 103,720
Change (%) 63.85 20.51 106.75 3.90 3.31 -49.21 18.84 5.53 2.61 101.18 -0.45 1.34 4.18 7.52 8.49 6.40 3.43 -4.41 -5.10
% of Revenue 4.53 7.27 8.67 16.85 16.99 17.08 8.47 9.80 10.01 9.93 19.31 18.72 18.46 18.77 19.75 21.11 21.97 22.16 20.79 19.29

Source: Capital IQ

Other Listings
IN:524715
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista